A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group

Clinical and Translational Radiation Oncology - Tập 34 - Trang 1-6 - 2022
Amelia Barcellini1, Maurizio Massaro2, Francesca Dal Mas3, Johannes A. Langendijk4, Morten Høyer5, Valentin Calugaru6, Karin Haustermans7, Beate Timmermann8, Juliette Thariat9, Daniele Scartoni10, Sabina Vennarini10,11, Petra Georg12, Ester Orlandi1
1Radiation Oncology, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy
2Department of Management, Ca’ Foscari University, Venice, Italy
3Department of Management, Lincoln International Business School, University of Lincoln, Lincoln, UK and Interdepartmental Research Center “Organization and Governance of the Public Administration”, University of Pavia, Pavia, Italy
4Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
5Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark
6Department of Radiation Oncology, Institut Curie, Paris, France
7Department of Radiation Oncology, University Hospital Leuven, Leuven, Belgium
8Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WTZ), German Cancer Consortium (DKTK), Germany
9Radiation Oncology Department, François Baclesse Center/ARCHADE, Normandy University, Caen, France
10Proton Therapy Unit, Hospital of Trento, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy
11Pediatric Radiotherapy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
12MedAustron Ion Therapy Center, Wiener Neustadt, Austria

Tài liệu tham khảo

WHO Coronavirus disease (COVID-19) Pandemic. Angelos, 2020, Surgeons, Ethics, and COVID-19: Early Lessons Learned, J. Am. Coll. Surg., 1–2 Barcellini, 2020, To a new normal in radiation oncology: looking back and planning forward, Tumori, 106, 440, 10.1177/0300891620962197 Curigliano, 2020, Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol., 31, 1320, 10.1016/j.annonc.2020.07.010 Siavashpour, 2021, Radiotherapy based management during Covid-19 pandemic – A systematic review of presented consensus and guidelines, Crit. Rev. Oncol. Hematol., 164, 103402, 10.1016/j.critrevonc.2021.103402 Price, 2020, Initiation of the Global Coalition for Radiotherapy during the COVID-19 pandemic, Lancet Oncol., 21, 752, 10.1016/S1470-2045(20)30281-3 Jereczek-Fossa, 2020, COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO), Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol., 149, 89, 10.1016/j.radonc.2020.04.061 Meattini, 2020, Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation’s young oncologists, ESMO open, 5, e000779, 10.1136/esmoopen-2020-000779 De Felice, 2021, A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group, Radiol. Med., 126, 343, 10.1007/s11547-020-01296-7 Filippi, 2020, Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak, International Journal of Radiation Oncology*Biology*Physics, 107, 597, 10.1016/j.ijrobp.2020.03.007 Guckenberger, 2020, Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol., 146, 223, 10.1016/j.radonc.2020.04.001 Loap, 2020, Breast radiation therapy during COVID-19 outbreak: Practical advice, Cancer Radiother Gregucci, 2020, Cancer patients in Covid-19 era: Swimming against the tide, Radiother. Oncol., 149, 109, 10.1016/j.radonc.2020.04.002 Bardet, 2021, Impact of COVID-19 on healthcare organisation and cancer outcomes, Eur. J. Cancer, 153, 123, 10.1016/j.ejca.2021.05.012 Nagar, 2020, Cancer and COVID-19 – potentially deleterious effects of delaying radiotherapy, Nat. Rev. Clin. Oncol., 17, 332, 10.1038/s41571-020-0375-1 Tey, 2020, Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol., 148, 189, 10.1016/j.radonc.2020.03.030 Barra, 2021, Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice, Radiol. Med., 126, 142, 10.1007/s11547-020-01216-9 Eysenbach, 2004, Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES), J. Med. Internet Res., 6, 10.2196/jmir.6.3.e34 Miceli L., Dal Mas F., Biancuzzi H., Bednarova R., Rizzardo A., Cobianchi L. et al. Doctor@Home: Through a Telemedicine Co-production and Co-learning Journey J Cancer Educ. 2021 Jan 14:1-3. doi: 10.1007/s13187-020-01945-5. Online ahead of print. Ballatore, 2022, Cancer patient perspective in the arena of COVID-19 pandemic, Psychooncology., 31, 39, 10.1002/pon.5774 Rashid, 2021, Psychological distress and moral injury to oncologists and their patients during COVID-19 pandemic, Curr. Psychol., 1–6 Dhada, 2021, Cancer Services During the COVID-19 Pandemic: Systematic Review of Patient’s and Caregiver’s Experiences, Cancer Manag. Res., 13, 5875, 10.2147/CMAR.S318115 Cobianchi, 2022, Hand in hand: A multistakeholder approach for Co-production of surgical care, Am. J. Surg., 223, 214, 10.1016/j.amjsurg.2021.07.053 Dvori, 2021, Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic, Int. J. Clin. Oncol., 26, 1569, 10.1007/s10147-021-01971-3 Parasole, 2020, Collateral effects of COVID-19 pandemic in pediatric hematooncology: Fatalities caused by diagnostic delay, Pediatr. Blood Cancer, 67, 10.1002/pbc.28482 Offenbacher, 2021, Delayed presentations of pediatric solid tumors at a tertiary care hospital in the Bronx due to COVID-19, Pediatr. Blood Cancer, 68, 10.1002/pbc.28615 Skovlund, 2021, Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark, Acta Oncol., 60, 20, 10.1080/0284186X.2020.1858235 Jacob, 2021, Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany, Cancers (Basel), 13, 408, 10.3390/cancers13030408 Kapsner, 2020, Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 Lockdown, Front. public Heal., 8 Maringe, 2020, The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study, Lancet. Oncol., 21, 1023, 10.1016/S1470-2045(20)30388-0 Barcellini, 2020, Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak?, Pancreatology, 20, 1004, 10.1016/j.pan.2020.05.007 Ronchi, 2020, Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: is this the right time for particle therapy?, Oral Oncol., 106, 104803, 10.1016/j.oraloncology.2020.104803 Chen, 2021, The impact of COVID-19 on the clinical trial, PLoS ONE, 16, e0251410, 10.1371/journal.pone.0251410 Scarcia, 2020, Patients with cancer in the COVID-19 era: the clinical trial issue, Tumori, 106, 271, 10.1177/0300891620933672 Høyer, 2021, Research in radiation oncology and the Covid-19 pandemic, Acta Oncol., 60, 275, 10.1080/0284186X.2021.1890334